BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 38357312)

  • 1. Research progress on cuproptosis in cancer.
    Feng Q; Huo C; Wang M; Huang H; Zheng X; Xie M
    Front Pharmacol; 2024; 15():1290592. PubMed ID: 38357312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cuproptosis in cancer: biological implications and therapeutic opportunities.
    Li L; Zhou H; Zhang C
    Cell Mol Biol Lett; 2024 Jun; 29(1):91. PubMed ID: 38918694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuproptosis: Mechanism, role, and advances in urological malignancies.
    Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
    Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuproptosis is involved in copper-induced hepatotoxicity in chickens.
    Zhong G; Li L; Li Y; Ma F; Liao J; Li Y; Zhang H; Pan J; Hu L; Tang Z
    Sci Total Environ; 2023 Mar; 866():161458. PubMed ID: 36621474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
    Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
    Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulus-Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy.
    Hu F; Huang J; Bing T; Mou W; Li D; Zhang H; Chen Y; Jin Q; Yu Y; Yang Z
    Adv Sci (Weinh); 2024 Apr; 11(13):e2309388. PubMed ID: 38269649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression.
    Zhao Q; Qi T
    Front Oncol; 2023; 13():1117164. PubMed ID: 36925927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis: potential new direction in diabetes research and treatment.
    Qu J; Wang Y; Wang Q
    Front Endocrinol (Lausanne); 2024; 15():1344729. PubMed ID: 38904034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma.
    Ozkan E; Bakar-Ates F
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17663-17670. PubMed ID: 37843555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy.
    Chang J; Yin W; Zhi H; Chen S; Sun J; Zhao Y; Huang L; Xue L; Zhang X; Zhang T; Dong H; Li Y
    Small; 2024 Feb; ():e2308565. PubMed ID: 38339770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
    Yuan HJ; Xue YT; Liu Y
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis and Cuproptosis-Based Synergistic Therapy for Cancer Treatment.
    Shen Z; Qiu Y; Ding H; Ren F; Chen H
    ChemMedChem; 2024 Jun; ():e202400216. PubMed ID: 38943463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cuproptosis: p53-regulated metabolic cell death?
    Xiong C; Ling H; Hao Q; Zhou X
    Cell Death Differ; 2023 Apr; 30(4):876-884. PubMed ID: 36755067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
    Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
    Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis-a potential target for the treatment of osteoporosis.
    Li D; Gao Z; Li Q; Liu X; Liu H
    Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Molecular Mechanisms of Cuproptosis and Small-Molecule Drug Design in Diabetes Mellitus.
    Pan Z; Huang L; Gan Y; Xia Y; Yu W
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuproptosis: mechanisms and links with cancers.
    Xie J; Yang Y; Gao Y; He J
    Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper homeostasis and cuproptosis in cancer immunity and therapy.
    Liu WQ; Lin WR; Yan L; Xu WH; Yang J
    Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Molecular Subtyping Scheme Based on In Silico Analysis of Cuproptosis Regulator Gene Patterns Optimizes Survival Prediction and Treatment of Hepatocellular Carcinoma.
    Jiang H; Chen H; Wang Y; Qian Y
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of cuproptosis in Parkinson's disease.
    Huang M; Zhang Y; Liu X
    Ageing Res Rev; 2024 Mar; 95():102214. PubMed ID: 38311254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.